AMH is a hormone produced by reproductive tissues; it is produced in the testicles in males and in the ovaries in females. The role of AMH and the amount normally present varies depending upon gender and age.
AMH can be measured in women to evaluate ovarian function and fertility, or to evaluate the effectiveness of ovarian cancer treatment (in AMH producing ovarian tumours). It can be increased in polycystic ovary syndrome (PCOS).
It can also be used to evaluate the presence of ambiguous genitals and/or function of the testicles in an infant boy.
(Source: Lab Tests Online)
Copyright heftpathology 2013, 2014, 2015, 2016, 2017, 2018
HTA licence number is 12366
Protection of Personal Information – Laboratory Medicine comply with the Trust Data Protection Policy and have procedures in place to allow the Directorate and it’s employees to comply with the Data Protection Act 1998 and associated best practice and guidance.
The Trust Laboratories at Heartlands Hospital, Good Hope Hospital and Solihull Hospital were awarded UKAS (United Kingdom Accreditation Service) accreditation to the internationally recognised ISO 15189 standard in May 2015. For a list of accredited tests and other information please visit the test database http://www.heftpathology.com/frontpage/test-database.html.
Tests not appearing on this scope are either under consideration or in the process of accreditation and so currently remain outside of our scope of accreditation. However, these tests have been validated to the same high standard as accredited tests and are performed by the same trained and competent staff.
For further information contact Louise Fallon, Quality Manager, 0121 424 1235